340B PATIENTS Act of 2025

This bill clarifies and strengthens the 340B drug discount program, which allows community health centers, hospitals, and clinics (covered entities) to purchase medications at discounted prices. It explicitly requires drug manufacturers to offer these discounts regardless of where drugs are dispensed (including through contracted pharmacies) and prohibits manufacturers from adding conditions that restrict how covered entities use these discounts - such as limiting delivery locations or demanding extra data. The bill also establishes civil penalties of up to $2 million per day for manufacturers who violate these rules, and allows covered entities to file claims for violations. This directly affects safety-net providers who rely on 340B savings to access specialty drugs (like cancer treatments) for patients in underserved communities.